Industrial production of mesenchymal stem cells to drive down the cost of regenerative therapies.
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Funding round Cellcolabs raised $12 million led by Titian Capital to scale stem cell production. | $12M |
| Mar 2024 | Funding round Cellcolabs raised $8.7M in an oversubscribed round from unicorn founders and existing investors to scale its stem cell production. | $8.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.